Article: First Once-Daily Treatment Cleared by FDA for Suppression of Genital Herpes Outbreaks

RESEARCH TRIANGLE PARK, N.C., Sept. 29 /PRNewswire/ -- Men and women who suffer from the discomfort and disruption caused by recurrent genital herpes outbreaks now have a once-a-day treatment option for suppressing these outbreaks.

The U.S. Food and Drug Administration today cleared Valtrex(R) (valacyclovir HCl) Caplets for use as a once daily therapy for the suppression of genital herpes. Valtrex has been shown in clinical trials of otherwise healthy adults to have a significant effect in suppressing outbreaks compared to placebo. As of August, 1997, Valtrex became the most widely used branded antiherpetic medication (Source Prescription Audit -- August, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!